Aimco Pesticides Limited (BOM:524288)
85.46
+2.80 (3.39%)
At close: Jul 29, 2025
Theseus Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | -72.43 | -100.46 | -21.85 | 106.6 | 21 | Upgrade |
Depreciation & Amortization | 40.94 | 42.71 | 36.11 | 27.41 | 21.97 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | -0.61 | 0.27 | 0.06 | Upgrade |
Loss (Gain) From Sale of Investments | -0.02 | - | -0.91 | -0.08 | -0.13 | Upgrade |
Provision & Write-off of Bad Debts | -0.11 | -0.87 | 0.51 | -0.72 | 1.14 | Upgrade |
Other Operating Activities | 24.08 | -7.24 | 1.35 | 21.47 | 22.75 | Upgrade |
Change in Accounts Receivable | -38.83 | -218.15 | 162.49 | -152.63 | 35.7 | Upgrade |
Change in Inventory | -205.46 | 253.39 | 1.76 | -165.88 | -30.41 | Upgrade |
Change in Accounts Payable | 312.12 | 73.68 | -343.5 | 368.11 | 54.35 | Upgrade |
Change in Other Net Operating Assets | -33.53 | 27.94 | 63.81 | 21.35 | -48.18 | Upgrade |
Operating Cash Flow | 26.76 | 70.99 | -100.84 | 225.91 | 78.25 | Upgrade |
Operating Cash Flow Growth | -62.30% | - | - | 188.72% | 143.29% | Upgrade |
Capital Expenditures | -11.92 | -54.23 | -66.75 | -78.05 | -41.91 | Upgrade |
Sale of Property, Plant & Equipment | - | - | 1.02 | 0.19 | 0.22 | Upgrade |
Sale (Purchase) of Intangibles | -5.21 | -9.9 | 4.05 | 28.65 | -19.18 | Upgrade |
Investment in Securities | 0.18 | -0.01 | 41.06 | -40 | -0.09 | Upgrade |
Other Investing Activities | -0.2 | 0.25 | -0.72 | 0.22 | 0.62 | Upgrade |
Investing Cash Flow | -17.14 | -63.89 | -21.34 | -88.98 | -60.34 | Upgrade |
Short-Term Debt Issued | 29.28 | 39.75 | 126.03 | - | - | Upgrade |
Long-Term Debt Issued | - | 18.06 | - | - | 19 | Upgrade |
Total Debt Issued | 29.28 | 57.81 | 126.03 | - | 19 | Upgrade |
Short-Term Debt Repaid | - | - | - | -103.55 | - | Upgrade |
Long-Term Debt Repaid | -18.8 | -6.87 | -1.65 | -6.43 | -15.01 | Upgrade |
Total Debt Repaid | -18.8 | -6.87 | -1.65 | -109.99 | -15.01 | Upgrade |
Net Debt Issued (Repaid) | 10.47 | 50.94 | 124.38 | -109.99 | 3.99 | Upgrade |
Issuance of Common Stock | 20.2 | - | - | - | - | Upgrade |
Common Dividends Paid | - | -10.32 | -20.6 | -8.84 | -3.48 | Upgrade |
Other Financing Activities | -30.82 | -27.19 | -10.66 | -15.95 | -36.95 | Upgrade |
Financing Cash Flow | -0.15 | 13.43 | 93.13 | -134.79 | -36.44 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | - | - | -0 | -0 | Upgrade |
Net Cash Flow | 9.48 | 20.54 | -29.05 | 2.15 | -18.54 | Upgrade |
Free Cash Flow | 14.84 | 16.77 | -167.6 | 147.86 | 36.34 | Upgrade |
Free Cash Flow Growth | -11.46% | - | - | 306.93% | 3950.72% | Upgrade |
Free Cash Flow Margin | 0.75% | 0.81% | -8.11% | 4.73% | 2.04% | Upgrade |
Free Cash Flow Per Share | 1.55 | 1.75 | -17.49 | 15.43 | 3.79 | Upgrade |
Cash Interest Paid | 30.94 | 26.45 | 9.23 | 15.22 | 40.43 | Upgrade |
Cash Income Tax Paid | -16.76 | - | 17.1 | 31.7 | 33.14 | Upgrade |
Levered Free Cash Flow | -3.67 | 18.18 | -154.35 | 146.81 | -34.93 | Upgrade |
Unlevered Free Cash Flow | 15.67 | 34.71 | -139.32 | 156.02 | -7.49 | Upgrade |
Change in Net Working Capital | -39.97 | -127.41 | 111.21 | -76.96 | 12.18 | Upgrade |
Updated Jan 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.